Sign inJoin waitlistJoin the waitlist

PC

Paula Clemens

Vice Chair of Clinical Research · UPMC Medical Education

Credentials: · · ·

History

Clinical Research · UPMC Medical Education
Present
UPMC Medical Education
Present

Neurology
Dartmouth-Hitchcock Medical Center
1988–1992
Medical Genetics and Genomics
Baylor College of Medicine
1985–1987
Mayo Clinic
1984–1985
Drexel University College of Medicine
1980–1984

Research

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
Review · The Lancet Neurology · 2010 · 1,430 citations
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management
Review · The Lancet Neurology · 2018 · 996 citations
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care
Review · The Lancet Neurology · 2010 · 804 citations

Craig McDonald
29 papers
ES
Edward Smith
14 papers
Anne Connolly
12 papers
Nancy Kuntz
11 papers
AH
Amy Harper
10 papers
LC
Laurie Conklin
10 papers
Richard Finkel
9 papers
DE
Diana Escolar
8 papers
Priya Kishnani
8 papers · 3 as a resident
DC
Diana Castro
7 papers
Susan Iannaccone
7 papers
Christopher Spurney
5 papers

Grants

Network of Excellence in Neuroscience Clinical Trials (University of Pittsburgh CRS)
National Institute of Neurological Disorders and Stroke · U24
Contact PI · $3.3M · University of Pittsburgh at Pittsburgh
2018–2028
Vamorolone Trial in Becker Muscular Dystrophy
Food and Drug Administration · R01
PI · $1.2M · Reveragen Biopharma, Inc.
2021–2025
Pilot Trial of Vamorolone for the Treatment of Becker Muscular Dystrophy
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R21
Contact PI · $547.3K · University of Pittsburgh at Pittsburgh
2020–2025
Establishing a Cost-Effective Return of Results to Parents of Boys in VISION-DMD Clinical Trials
National Institute of Neurological Disorders and Stroke · R44
PI · $6.1M · Reveragen Biopharma, Inc.
2016–2020

Clinical trials

A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD)
Study chair · Completed · Phase 2
ReveraGen BioPharma, Inc.
2022–2025
A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
Study chair · Completed · Phase 2
ReveraGen BioPharma, Inc.
2018–2021
Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)
Study chair · Completed · Phase 2
NS Pharma, Inc.
2017–2021
Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
Study chair · Completed · Phase 2
ReveraGen BioPharma, Inc.
2017–2020